THE NEW ENGLAND COUNCIL

Lobbying for NEW ENGLAND COUNCIL

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 15, 2026

Expenses

$10,000.00

What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 4

HOUSE OF REPRESENTATIVES
Housing & Urban Development, Dept of (HUD)
SENATE
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 4

HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
HR 3383
Employee Equity Investment Act of 2023
HR 2441
Improving Disclosure for Investors Act of 2025

Lobbying activity 4

Health Issues

H.R. 5343/S. 1717 - Ensuring Patient Access to Critical Breakthroughs Act

Trade (domestic/foreign)

Support for United States Mexico Canada Agreement (USMCA)

Financial Institutions/Investments/Securities

H.R. 3383 - INVEST Act H.R. 2441 - Improving Disclosure for Investors Act

Housing

Changes to U.S. Department of Housing & Urban Development Continuum of Care Program

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.